Kerr Grieve is a research fellow in the Medicines Monitoring Unit, University of Dundee. He is training in clinical neurology, and his research interests lie understanding the current therapeutic use of disease modifying therapy in multiple sclerosis, and trial design.
Dr. Grieve is involved with the day-to-day running of the clinical trials run by MEMO, and is undertaking epidemiological studies of multiple sclerosis in pursuit of a higher degree. He is interested in patient self-reported outcome measures, utilising routinely collected data and developing an early disease MS cohort within Scotland.
3rd year MBChB neurology clinical teaching
Grieve J., Cruickshank M., Cleland J., "Using a consensus method to develop labour ward learning objectives" The Clinical Teacher, 2009:6:185-189.
Steinfort D.P., Tsui A., Grieve J., et al. "Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case-control study" Human Pathology. 2012 Mar;43(3):333-8.
Mcleod A.D., Grieve J.W.K., Counsell C.E., “A systematic review of loss of independence in Parkinson’s disease” Journal of Neurology, 2016, 263:1